Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
43.08
-0.25 (-0.58%)
At close: Oct 27, 2025, 4:00 PM EDT
43.08
0.00 (0.00%)
After-hours: Oct 27, 2025, 5:43 PM EDT
Agios Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts that cover Agios Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $59.33, which forecasts a 37.72% increase in the stock price over the next year. The lowest target is $56 and the highest is $65.
Price Target: $59.33 (+37.72%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 4, 2025.
Analyst Ratings
The average analyst rating for Agios Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Hold | 3 | 3 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 6 | 6 | 6 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $56 | Strong Buy | Reiterates | $56 | +29.99% | Sep 4, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $71 → $65 | Buy | Maintains | $71 → $65 | +50.88% | Jul 28, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $52 → $51 | Strong Buy | Maintains | $52 → $51 | +18.38% | Jul 22, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $74 → $71 | Buy | Maintains | $74 → $71 | +64.81% | May 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $58 | Strong Buy | Reiterates | $58 | +34.63% | Feb 24, 2025 |
Financial Forecast
Revenue This Year
45.16M
from 36.50M
Increased by 23.74%
Revenue Next Year
117.38M
from 45.16M
Increased by 159.90%
EPS This Year
-7.55
from 11.64
EPS Next Year
-7.45
from -7.55
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 50.3M | 151.9M | |||
| Avg | 45.2M | 117.4M | |||
| Low | 39.2M | 75.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 37.8% | 236.4% | |||
| Avg | 23.7% | 159.9% | |||
| Low | 7.4% | 67.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -7.34 | -6.14 | |||
| Avg | -7.55 | -7.45 | |||
| Low | -7.53 | -9.15 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.